Thromb Haemost 2015; 114: 1–210

ISSN 0340-6245 E 3185

ThrombosisandHaemostasis

International Journalfor Vascular Biology and Medicine

www.schattauer.dewww.thrombosis-online.com

Highlights

Volume 114Number 1July 2015

RE-VERSE AD: Phase 3 study of idarucizumab as a reversal agent for dabigatran ■ Modulation of microRNAs and target proteome after platelet activation ■ tPA-binding RNA aptamers in treatment of cerebral ischaemic stroke ■ Stabilisation of atherosclerotic plaques by fibronectin extra domain A